Cellobiohydrolase variants

US8945903B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8945903-B2
Application numberUS-201213549300-A
CountryUS
Kind codeB2
Filing dateJul 13, 2012
Priority dateAug 23, 2011
Publication dateFeb 3, 2015
Grant dateFeb 3, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to cellobiohydrolase variants having improved thermostability in comparison to wild-type CBH2a.

First claim

Opening claim text (preview).

What is claimed is: 1. A recombinant cellobiohydrolase type 2a (CBH2a) variant comprising at least about 90% sequence identity to SEQ ID NO:1 and comprising an amino acid substitution, relative to SEQ ID NO:1, at one or more positions selected from 15, 204, and 340, wherein the position is numbered with reference to SEQ ID NO:1. 2. The variant of claim 1 , wherein the amino acid residue at position 15 is phenylalanine, isoleucine, or serine (X15F/I/S); the amino acid residue at position 204 is tryptophan (X204W); and/or the amino acid residue at position 340 is serine (X340S). 3. The variant of claim 1 , further comprising an amino acid substitution, relative to SEQ ID NO:1, at one or more positions selected from 39, 113, and 250. 4. The variant of claim 3 , wherein the amino acid residue at position 39 is alanine or cysteine (X39A/C); the amino acid residue at position 113 is leucine or arginine (X113L/R); and/or the amino acid residue at position 250 is proline or valine (X250P/V). 5. The variant of claim 1 , wherein the variant is a Myceliophthora thermophila cellobiohydrolase. 6. The variant of claim 1 comprising at least 95% sequence identity to SEQ ID NO:1. 7. The variant of claim 1 that has increased thermostability after incubation at pH 5.0 and 55° C. for 1 hour in comparison to wild-type Myceliophthora thermophila CBH2a (SEQ ID NO:1). 8. A recombinant cellobiohydrolase type 2 (CBH2) variant comprising at least 90% sequence identity to SEQ ID NO:1 and comprising an amino acid substitution selected from: a glutamine, arginine, or tryptophan residue at position 204 (X204Q/R/W); wherein the position is numbered with reference to SEQ ID NO:1, and wherein the cellobiohydrolase variant has increased thermostability in comparison to the wild-type cellobiohydrolase from which the variant is derived. 9. An enzyme composition comprising the variant cellobiohydrolase polypeptide of claim 1 . 10. A method of producing a fermentable sugar from a cellulosic substrate, comprising contacting the cellulosic substrate with a β-glucosidase (Bgl), a type 2 endoglucanase (EG2), a type 1a cellobiohydrolase (CBH1a), a glycoside hydrolase 61 protein (GH61), and the CBH2a variant of claim 1 under conditions in which the fermentable sugar is produced. 11. The method of claim 10 , comprising: contacting the fermentable sugar with a microorganism in a fermentation to produce an end-product. 12. The method of claim 11 , wherein the end-product is an alcohol, an amino acid, an organic acid, a diol, or glycerol. 13. The variant of claim 8 , wherein the variant further comprises one or more amino acid substitutions selected from: an alanine, cysteine, lysine, proline, arginine, or valine residue at position 39 (X39A/C/K/P/R/V); and a cysteine, histidine, lysine, asparagine, proline, threonine, or valine at position 250 (X250C/H/K/N/P/T/V). 14. The variant of claim 8 , wherein the variant further comprises an amino acid substitution at one or more positions selected from 15, 39, 113, 250, and 340, wherein the position is numbered with reference to SEQ ID NO:1. 15. The variant of claim 14 , wherein: the amino acid substitution at position 15 is phenylalanine, isoleucine, or serine (X15F/I/S); the amino acid substitution at position 39 is alanine or cysteine (X39A/C/K/P/R/V); the amino acid substitution at position 113 is leucine or arginine (X113L/R/T); the amino acid substitution at position 250 is proline or valine (X250P/V); and/or the amino acid residue at position 340 is serine (X340S).

Assignees

Inventors

Classifications

  • Aldonic, ketoaldonic or saccharic acids (uronic acids C12P19/00) · CPC title

  • Cross-Sectional Technologies · mapped topic

  • Butanols · CPC title

  • Cellulose 1,4-beta-cellobiosidase (3.2.1.91) · CPC title

  • Glycerol · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8945903B2 cover?
The present invention relates to cellobiohydrolase variants having improved thermostability in comparison to wild-type CBH2a.
Who is the assignee on this patent?
Baidyaroy Dipnath, Clark Louis, Elgart David, and 3 more
What technology area does this patent fall under?
Primary CPC classification C12Y302/01091. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).